TRF1 as well as tankyrase, an inhibitor of TRF1, did not show significant differences in their expression levels between all tissues examined, including Burkitt's lymphoma (one-way analysis of variance, P=0.433 for TRF1 and P=0.508 for hPif1). The gene discussed is TERF1; the disease is Burkitt lymphoma.